Cytotoxic edema and diffusion restriction as an early pathoradiologic marker in canavan disease: case report and review of the literature

A case of Canavan disease with microcephaly

(2016) Vykuntaraju K. Gowda et al.   BRAIN & DEVELOPMENT

Non-genetic therapeutic approaches to Canavan disease

(2016) Rebecca B. Roscoe et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model

(2015) Fuzheng Guo et al.   ANNALS OF NEUROLOGY

N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time

(2015) H. Maier et al.   JOURNAL OF NEUROSCIENCE

Atypical clinical and radiological course of a patient with Canavan disease

(2015) Catherine Sarret et al.   METABOLIC BRAIN DISEASE

An Atypical Case of Canavan Disease With Stroke-Like Presentation

(2015) Katherine E. Delaney et al.   PEDIATRIC NEUROLOGY

Canavan disease, a rare early-onset human spongiform leukodystrophy: Insights into its genesis and possible clinical interventions

(2012) M.H. Baslow et al.   BIOCHIMIE

Relationship between enzyme properties and disease progression in Canavan disease

(2012) Stephen Zano et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Long-Term Follow-Up After Gene Therapy for Canavan Disease

(2012) P. Leone et al.   Science Translational Medicine

Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease

(2010) Mitra Assadi et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Developmental and regional distribution of aspartoacylase in rat brain tissue

(2003) Kishore K. Bhakoo et al.   JOURNAL OF NEUROCHEMISTRY